Download PDF
Semin Neurol 2017; 37(06): 632-642
DOI: 10.1055/s-0037-1608925
Review Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Reproductive Issues in MS

Maria K. Houtchens
1   Department of Neurology, Partners Multiple Sclerosis Center, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts
,
Tamara B. Kaplan
1   Department of Neurology, Partners Multiple Sclerosis Center, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts
› Author Affiliations
Further Information

Publication History

Publication Date:
21 December 2017 (online)

    Permissions and Reprints

Abstract

Multiple sclerosis (MS) is an autoimmune disease of the central nervous system, predominantly affecting women of childbearing age. Therefore, issues of conception, pregnancy, and delivery are of significant importance to patients and treating physicians. We discuss immunologic and clinical effects of pregnancy on the course of MS including both immunosuppression on a local level and a heightened state of immunocompetence on a global level. Clinical outcomes of the Pregnancy in Multiple Sclerosis trials are reported. We analyze and update the available data on safety and efficacy of immunomodulating MS treatments and symptomatic treatments for pregnant and lactating women, and address specific issues of MS management at the time of pregnancy. We review the data related to estrogen-based MS therapies currently or previously in trials. Pregnancy does not appear to be associated with adverse outcomes in MS patients. Some evidence suggests possible beneficial effects, although clear prospective data of sufficient length and quality are limited. Long-term relapse rates or disability progression do not seem to be affected by pregnancy in MS patients. The use of immunosuppressive or immunomodulatory agents in pregnancy is not routinely advisable but could be considered under special circumstances.

Keywords

multiple sclerosis - pregnancy - treatment - outcomes
 

  • References

  • 1 Douglass LH, Jorgensen CL. Pregnancy and multiple sclerosis. Am J Obstet Gynecol 1948; 55 (02) 332-336
    CrossrefPubMedGoogle Scholar
  • 2 Confavreux C, Hutchinson M, Hours MM, Cortinovis-Tourniaire P, Moreau T. ; Pregnancy in Multiple Sclerosis Group. Rate of pregnancy-related relapse in multiple sclerosis. N Engl J Med 1998; 339 (05) 285-291
    CrossrefPubMedGoogle Scholar
  • 3 Vukusic S, Hutchinson M, Hours M. , et al; Pregnancy In Multiple Sclerosis Group. Pregnancy and multiple sclerosis (the PRIMS study): clinical predictors of post-partum relapse. Brain 2004; 127 (Pt 6): 1353-1360
    CrossrefPubMedGoogle Scholar
  • 4 Houtchens MK, Zapata LB, Curtis KM, Whiteman MK. Contraception for women with multiple sclerosis: guidance for healthcare providers. Mult Scler 2017; 23 (06) 757-764
    CrossrefPubMedGoogle Scholar
  • 5 Rossouw JE, Anderson GL, Prentice RL. , et al; Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA 2002; 288 (03) 321-333
    CrossrefPubMedGoogle Scholar
  • 6 Thorogood M, Hannaford PC. The influence of oral contraceptives on the risk of multiple sclerosis. Br J Obstet Gynaecol 1998; 105 (12) 1296-1299
    CrossrefPubMedGoogle Scholar
  • 7 Alonso A, Jick SS, Olek MJ, Ascherio A, Jick H, Hernán MA. Recent use of oral contraceptives and the risk of multiple sclerosis. Arch Neurol 2005; 62 (09) 1362-1365
    CrossrefPubMedGoogle Scholar
  • 8 Dwosh E, Guimond C, Sadovnick AD. Reproductive counselling for MS: a rationale. Int MS J 2003; 10 (02) 52-59
    PubMedGoogle Scholar
  • 9 Zorzon M, Zivadinov R, Bosco A. , et al. Sexual dysfunction in multiple sclerosis: a case-control study. I. Frequency and comparison of groups. Mult Scler 1999; 5 (06) 418-427
    CrossrefPubMedGoogle Scholar
  • 10 Sadovnick AD, Dircks A, Ebers GC. Genetic counselling in multiple sclerosis: risks to sibs and children of affected individuals. Clin Genet 1999; 56 (02) 118-122
    CrossrefPubMedGoogle Scholar
  • 11 Willer CJ, Dyment DA, Risch NJ, Sadovnick AD, Ebers GC. ; Canadian Collaborative Study Group. Twin concordance and sibling recurrence rates in multiple sclerosis. Proc Natl Acad Sci U S A 2003; 100 (22) 12877-12882
    CrossrefPubMedGoogle Scholar
  • 12 Oksenberg JR. Decoding multiple sclerosis: an update on genomics and future directions. Expert Rev Neurother 2013; 13 (12, Suppl): 11-19
    CrossrefPubMedGoogle Scholar
  • 13 Hughes MD. Multiple sclerosis and pregnancy. Neurol Clin 2004; 22 (04) 757-769
    CrossrefPubMedGoogle Scholar
  • 14 Sadovnick AD, Baird PA, Ward RH. Multiple sclerosis: updated risks for relatives. Am J Med Genet 1988; 29 (03) 533-541
    CrossrefPubMedGoogle Scholar
  • 15 Hunt JS. Immunobiology of pregnancy. Curr Opin Immunol 1992; 4 (05) 591-596
    CrossrefPubMedGoogle Scholar
  • 16 Damek DM, Shuster EA. Pregnancy and multiple sclerosis. Mayo Clin Proc 1997; 72 (10) 977-989
    CrossrefPubMedGoogle Scholar
  • 17 Athanasas-Platsis S, Zhang B, Hillyard NC. , et al. Early pregnancy factor suppresses the infiltration of lymphocytes and macrophages in the spinal cord of rats during experimental autoimmune encephalomyelitis but has no effect on apoptosis. J Neurol Sci 2003; 214 (1-2): 27-36
    CrossrefPubMedGoogle Scholar
  • 18 Drew PD, Chavis JA. Female sex steroids: effects upon microglial cell activation. J Neuroimmunol 2000; 111 (1-2): 77-85
    CrossrefPubMedGoogle Scholar
  • 19 Gilmore W, Arias M, Stroud N, Stek A, McCarthy KA, Correale J. Preliminary studies of cytokine secretion patterns associated with pregnancy in MS patients. J Neurol Sci 2004; 224 (1-2): 69-76
    CrossrefPubMedGoogle Scholar
  • 20 Abramsky O, Brenner T, Mizrachi R, Soffer D. Alpha-fetoprotein suppresses experimental allergic encephalomyelitis. J Neuroimmunol 1982; 2 (01) 1-7
    CrossrefPubMedGoogle Scholar
  • 21 Altman DJ, Schneider SL, Thompson DA, Cheng HL, Tomasi TB. A transforming growth factor beta 2 (TGF-beta 2)-like immunosuppressive factor in amniotic fluid and localization of TGF-beta 2 mRNA in the pregnant uterus. J Exp Med 1990; 172 (05) 1391-1401
    CrossrefPubMedGoogle Scholar
  • 22 Correale J, Gilmore W, McMillan M. , et al. Patterns of cytokine secretion by autoreactive proteolipid protein-specific T cell clones during the course of multiple sclerosis. J Immunol 1995; 154 (06) 2959-2968
    PubMedGoogle Scholar
  • 23 Byrnes AA, McArthur JC, Karp CL. Interferon-beta therapy for multiple sclerosis induces reciprocal changes in interleukin-12 and interleukin-10 production. Ann Neurol 2002; 51 (02) 165-174
    CrossrefPubMedGoogle Scholar
  • 24 López C, Comabella M, Tintoré M, Sastre-Garriga J, Montalban X. Variations in chemokine receptor and cytokine expression during pregnancy in multiple sclerosis patients. Mult Scler 2006; 12 (04) 421-427
    CrossrefPubMedGoogle Scholar
  • 25 Saraste M, Ryynänen J, Alanen A. , et al. Cerebrospinal fluid findings in multiple sclerosis patients before, during and after pregnancy. J Neurol Neurosurg Psychiatry 2006; 77 (10) 1195-1196
    CrossrefPubMedGoogle Scholar
  • 26 Weinshenker BG, Bass B, Rice GP. , et al. The natural history of multiple sclerosis: a geographically based study. I. Clinical course and disability. Brain 1989; 112 (Pt 1): 133-146
    CrossrefPubMedGoogle Scholar
  • 27 Frith JA, McLeod JG. Pregnancy and multiple sclerosis. J Neurol Neurosurg Psychiatry 1988; 51 (04) 495-498
    CrossrefPubMedGoogle Scholar
  • 28 Birk K, Ford C, Smeltzer S, Ryan D, Miller R, Rudick RA. The clinical course of multiple sclerosis during pregnancy and the puerperium. Arch Neurol 1990; 47 (07) 738-742
    CrossrefPubMedGoogle Scholar
  • 29 Vukusic S, Confavreux C. Pregnancy and multiple sclerosis: the children of PRIMS. Clin Neurol Neurosurg 2006; 108 (03) 266-270
    CrossrefPubMedGoogle Scholar
  • 30 Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983; 33 (11) 1444-1452
    CrossrefPubMedGoogle Scholar
  • 31 Paavilainen T, Kurki T, Parkkola R. , et al. Magnetic resonance imaging of the brain used to detect early post-partum activation of multiple sclerosis. Eur J Neurol 2007; 14 (11) 1216-1221
    CrossrefPubMedGoogle Scholar
  • 32 Salemi G, Callari G, Gammino M. , et al. The relapse rate of multiple sclerosis changes during pregnancy: a cohort study. Acta Neurol Scand 2004; 110 (01) 23-26
    CrossrefPubMedGoogle Scholar
  • 33 Masera S, Cavalla P, Prosperini L. , et al. Parity is associated with a longer time to reach irreversible disability milestones in women with multiple sclerosis. Mult Scler 2015; 21 (10) 1291-1297
    CrossrefPubMedGoogle Scholar
  • 34 D'hooghe MB, Nagels G, Uitdehaag BM. Long-term effects of childbirth in MS. J Neurol Neurosurg Psychiatry 2010; 81 (01) 38-41
    CrossrefPubMedGoogle Scholar
  • 35 van der Kop ML, Pearce MS, Dahlgren L. , et al. Neonatal and delivery outcomes in women with multiple sclerosis. Ann Neurol 2011; 70 (01) 41-50
    CrossrefPubMedGoogle Scholar
  • 36 Runmarker B, Andersen O. Pregnancy is associated with a lower risk of onset and a better prognosis in multiple sclerosis. Brain 1995; 118 (Pt 1): 253-261
    CrossrefPubMedGoogle Scholar
  • 37 Stenager E, Stenager EN, Jensen K. Effect of pregnancy on the prognosis for multiple sclerosis. A 5-year follow up investigation. Acta Neurol Scand 1994; 90 (05) 305-308
    PubMedGoogle Scholar
  • 38 Mueller BA, Zhang J, Critchlow CW. Birth outcomes and need for hospitalization after delivery among women with multiple sclerosis. Am J Obstet Gynecol 2002; 186 (03) 446-452
    CrossrefPubMedGoogle Scholar
  • 39 Worthington J, Jones R, Crawford M, Forti A. Pregnancy and multiple sclerosis--a 3-year prospective study. J Neurol 1994; 241 (04) 228-233
    CrossrefPubMedGoogle Scholar
  • 40 Dahl J, Myhr KM, Daltveit AK, Hoff JM, Gilhus NE. Pregnancy, delivery, and birth outcome in women with multiple sclerosis. Neurology 2005; 65 (12) 1961-1963
    CrossrefPubMedGoogle Scholar
  • 41 Coyle PK. Management of women with multiple sclerosis through pregnancy and after childbirth. Ther Adv Neurol Disorder 2016; 9 (03) 198-210
    PubMedGoogle Scholar
  • 42 Coyle PK, Sinclair SM, Scheuerle AE, Thorp Jr JM, Albano JD, Rametta MJ. Final results from the Betaseron (interferon β-1b) Pregnancy Registry: a prospective observational study of birth defects and pregnancy-related adverse events. BMJ Open 2014; 4 (05) e004536
    CrossrefPubMedGoogle Scholar
  • 43 Thiel S, Langer-Gould A, Rockhoff M. , et al. Interferon-beta exposure during first trimester is safe in women with multiple sclerosis-A prospective cohort study from the German Multiple Sclerosis and Pregnancy Registry. Mult Scler 2016; 22 (06) 801-809
    CrossrefPubMedGoogle Scholar
  • 44 Amato MP, Portaccio E, Ghezzi A. , et al; MS Study Group of the Italian Neurological Society. Pregnancy and fetal outcomes after interferon-β exposure in multiple sclerosis. Neurology 2010; 75 (20) 1794-1802
    CrossrefPubMedGoogle Scholar
  • 45 Boskovic R, Wide R, Wolpin J, Bauer DJ, Koren G. The reproductive effects of beta interferon therapy in pregnancy: a longitudinal cohort. Neurology 2005; 65 (06) 807-811
    CrossrefPubMedGoogle Scholar
  • 46 Patti F, Cavallaro T, Lo Fermo S. , et al. Is in utero early-exposure to interferon beta a risk factor for pregnancy outcomes in multiple sclerosis?. J Neurol 2008; 255 (08) 1250-1253
    CrossrefPubMedGoogle Scholar
  • 47 Hellwig K, Haghikia A, Rockhoff M, Gold R. Multiple sclerosis and pregnancy: experience from a nationwide database in Germany. Ther Adv Neurol Disorder 2012; 5 (05) 247-253
    CrossrefPubMedGoogle Scholar
  • 48 Waubant E, Sadovnick AD. Interferon beta babies. Neurology 2005; 65 (06) 788-789
    CrossrefPubMedGoogle Scholar
  • 49 Fragoso YD, Finkelsztejn A, Kaimen-Maciel DR. , et al. Long-term use of glatiramer acetate by 11 pregnant women with multiple sclerosis: a retrospective, multicentre case series. CNS Drugs 2010; 24 (11) 969-976
    PubMedGoogle Scholar
  • 50 Herbstritt S, Langer-Gould A, Rockhoff M. , et al. Glatiramer acetate during early pregnancy: a prospective cohort study. Mult Scler 2016; 22 (06) 810-816
    CrossrefPubMedGoogle Scholar
  • 51 Hellwig K. Pregnancy in multiple sclerosis. Eur Neurol 2014; 72 (Suppl. 01) 39-42
    CrossrefPubMedGoogle Scholar
  • 52 Gold R, Phillips JT, Havrdova E. , et al. Delayed-release dimethyl fumarate and pregnancy: preclinical studies and pregnancy outcomes from clinical trials and postmarketing experience. Neurol Ther 2015; 4 (02) 93-104
    CrossrefPubMedGoogle Scholar
  • 53 Tecfidera, Dimethyl Fumarte [package insert]. Cambridge, MA: Biogen Idec.; 2014
    Google Scholar
  • 54 Karlsson G, Francis G, Koren G. , et al. Pregnancy outcomes in the clinical development program of fingolimod in multiple sclerosis. Neurology 2014; 82 (08) 674-680
    CrossrefPubMedGoogle Scholar
  • 55 Houtchens MK, Sadovnick AD. Health Issues in Women with Multiple Sclerosis. Vienna, Austria: Springer; 2017
    Google Scholar
  • 56 Hatcher SE, Waubant E, Nourbakhsh B, Crabtree-Hartman E, Graves JS. Rebound syndrome in patients with multiple sclerosis after cessation of fingolimod treatment. JAMA Neurol 2016; 73 (07) 790-794
    CrossrefPubMedGoogle Scholar
  • 57 Vukusic S, Marignier R. Multiple sclerosis and pregnancy in the ‘treatment era’. Nat Rev Neurol 2015; 11 (05) 280-289
    CrossrefPubMedGoogle Scholar
  • 58 Daclizumab [package insert]. Cambridge, MA: Biogen Idec; 2016
    Google Scholar
  • 59 Chakravarty EF, Murray ER, Kelman A, Farmer P. Pregnancy outcomes after maternal exposure to rituximab. Blood 2011; 117 (05) 1499-1506
    CrossrefPubMedGoogle Scholar
  • 60 Ocrevus [package insert]. South San Francisco, CA: Genentech, Inc.; 2017
    Google Scholar
  • 61 de Seze J, Chapelotte M, Delalande S, Ferriby D, Stojkovic T, Vermersch P. Intravenous corticosteroids in the postpartum period for reduction of acute exacerbations in multiple sclerosis. Mult Scler 2004; 10 (05) 596-597
    CrossrefPubMedGoogle Scholar
  • 62 Janssen NM, Genta MS. The effects of immunosuppressive and anti-inflammatory medications on fertility, pregnancy, and lactation. Arch Intern Med 2000; 160 (05) 610-619
    CrossrefPubMedGoogle Scholar
  • 63 Penn I, Makowski E, Droegemueller W, Halgrimson CG, Starzl TE. Parenthood in renal homograft recipients. JAMA 1971; 216 (11) 1755-1761
    CrossrefPubMedGoogle Scholar
  • 64 Kozlowski RD, Steinbrunner JV, MacKenzie AH, Clough JD, Wilke WS, Segal AM. Outcome of first-trimester exposure to low-dose methotrexate in eight patients with rheumatic disease. Am J Med 1990; 88 (06) 589-592
    CrossrefPubMedGoogle Scholar
  • 65 Nguyen C, Duhl AJ, Escallon CS, Blakemore KJ. Multiple anomalies in a fetus exposed to low-dose methotrexate in the first trimester. Obstet Gynecol 2002; 99 (04) 599-602
    PubMedGoogle Scholar
  • 66 Bar Oz B, Hackman R, Einarson T, Koren G. Pregnancy outcome after cyclosporine therapy during pregnancy: a meta-analysis. Transplantation 2001; 71 (08) 1051-1055
    CrossrefPubMedGoogle Scholar
  • 67 Achiron A, Rotstein Z, Noy S, Mashiach S, Dulitzky M, Achiron R. Intravenous immunoglobulin treatment in the prevention of childbirth-associated acute exacerbations in multiple sclerosis: a pilot study. J Neurol 1996; 243 (01) 25-28
    PubMedGoogle Scholar
  • 68 van Walderveen MA, Tas MW, Barkhof F. , et al. Magnetic resonance evaluation of disease activity during pregnancy in multiple sclerosis. Neurology 1994; 44 (02) 327-329
    CrossrefPubMedGoogle Scholar
  • 69 Houtchens MK, Kaplan TB, Healy BR. , et al. Post-partum MRI activity in patients with multiple sclerosis. ECTRIMS Online Library. 10/8/2015; 115553
    PubMedGoogle Scholar
  • 70 Voskuhl RR, Palaszynski K. Sex hormones in experimental autoimmune encephalomyelitis: implications for multiple sclerosis. Neuroscientist 2001; 7 (03) 258-270
    CrossrefPubMedGoogle Scholar
  • 71 Vegeto E, Benedusi V, Maggi A. Estrogen anti-inflammatory activity in brain: a therapeutic opportunity for menopause and neurodegenerative diseases. Front Neuroendocrinol 2008; 29 (04) 507-519
    CrossrefPubMedGoogle Scholar
  • 72 Haghmorad D, Amini AA, Mahmoudi MB, Rastin M, Hosseini M, Mahmoudi M. Pregnancy level of estrogen attenuates experimental autoimmune encephalomyelitis in both ovariectomized and pregnant C57BL/6 mice through expansion of Treg and Th2 cells. J Neuroimmunol 2014; 277 (1-2): 85-95
    CrossrefPubMedGoogle Scholar
  • 73 Jansson L, Olsson T, Holmdahl R. Estrogen induces a potent suppression of experimental autoimmune encephalomyelitis and collagen-induced arthritis in mice. J Neuroimmunol 1994; 53 (02) 203-207
    CrossrefPubMedGoogle Scholar
  • 74 Sicotte NL, Liva SM, Klutch R. , et al. Treatment of multiple sclerosis with the pregnancy hormone estriol. Ann Neurol 2002; 52 (04) 421-428
    CrossrefPubMedGoogle Scholar
  • 75 Voskuhl RR, Wang H, Wu TC. , et al. Estriol combined with glatiramer acetate for women with relapsing-remitting multiple sclerosis: a randomised, placebo-controlled, phase 2 trial. Lancet Neurol 2016; 15 (01) 35-46
    CrossrefPubMedGoogle Scholar
  • 76 Rizvi SA, Bashir K. Other therapy options and future strategies for treating patients with multiple sclerosis. Neurology 2004; 63 (12) (Suppl. 06) S47-S54
    CrossrefPubMedGoogle Scholar
  • 77 Smith R, Studd JW. A pilot study of the effect upon multiple sclerosis of the menopause, hormone replacement therapy and the menstrual cycle. J R Soc Med 1992; 85 (10) 612-613
    PubMedGoogle Scholar
  • 78 Cocco E, Sardu C, Gallo P. , et al; FEMIMS Group. Frequency and risk factors of mitoxantrone-induced amenorrhea in multiple sclerosis: the FEMIMS study. Mult Scler 2008; 14 (09) 1225-1233
    CrossrefPubMedGoogle Scholar
  • 79 Bove R, Healy BC, Secor E. , et al. Patients report worse MS symptoms after menopause: findings from an online cohort. Mult Scler Relat Disord 2015; 4 (01) 18-24
    CrossrefPubMedGoogle Scholar
  • 80 Bove R, Healy BC, Musallam A, Glanz BI, De Jager PL, Chitnis T. Exploration of changes in disability after menopause in a longitudinal multiple sclerosis cohort. Mult Scler 2016; 22 (07) 935-943
    CrossrefPubMedGoogle Scholar